| Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy D Russo, A Pisani, MM Balletta, L De Nicola, FA Savino, M Andreucci, ... American journal of kidney diseases 33 (5), 851-856, 1999 | 354 | 1999 |
| Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy D Russo, R Minutolo, A Pisani, R Esposito, G Signoriello, M Andreucci, ... American Journal of Kidney Diseases 38 (1), 18-25, 2001 | 313 | 2001 |
| Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial A Caroli, N Perico, A Perna, L Antiga, P Brambilla, A Pisani, B Visciano, ... The Lancet 382 (9903), 1485-1495, 2013 | 291 | 2013 |
| Insomnia in maintenance haemodialysis patients M Sabbatini, B Minale, A Crispo, A Pisani, A Ragosta, R Esposito, ... Nephrology Dialysis Transplantation 17 (5), 852-856, 2002 | 291 | 2002 |
| Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome P Ruggenenti, B Ruggiero, P Cravedi, M Vivarelli, L Massella, M Marasà, ... Journal of the American Society of Nephrology 25 (4), 850-863, 2014 | 201 | 2014 |
| Acute kidney injury by radiographic contrast media: pathogenesis and prevention M Andreucci, T Faga, A Pisani, M Sabbatini, A Michael BioMed research international 2014, 2014 | 177 | 2014 |
| Metabolic effects of two low protein diets in chronic kidney disease stage 4–5—a randomized controlled trial B Cianciaruso, A Pota, A Pisani, S Torraca, R Annecchini, P Lombardi, ... Nephrology Dialysis Transplantation 23 (2), 636-644, 2008 | 157 | 2008 |
| Enzyme replacement therapy with agalsidase β improves cardiac involvement in Fabry's disease L Spinelli, A Pisani, M Sabbatini, M Petretta, MV Andreucci, D Procaccini, ... Clinical genetics 66 (2), 158-165, 2004 | 145 | 2004 |
| Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial A Pisani, E Riccio, M Sabbatini, M Andreucci, A Del Rio, B Visciano Nephrology dialysis transplantation 30 (4), 645-652, 2015 | 138 | 2015 |
| Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors M Andreucci, T Faga, A Pisani, M Sabbatini, D Russo, A Michael The Scientific World Journal 2014, 2014 | 133 | 2014 |
| Sleep quality in renal transplant patients: a never investigated problem M Sabbatini, A Crispo, A Pisani, R Gallo, B Cianciaruso, G Fuiano, ... Nephrology Dialysis Transplantation 20 (1), 194-198, 2005 | 131 | 2005 |
| Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature A Pisani, B Visciano, GD Roux, M Sabbatini, C Porto, G Parenti, ... Molecular genetics and metabolism 107 (3), 267-275, 2012 | 120 | 2012 |
| Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy A Pisani, E Riccio, M Andreucci, T Faga, M Ashour, A Di Nuzzi, A Mancini, ... BioMed research international 2013, 2013 | 118 | 2013 |
| Effect of a low-versus moderate-protein diet on progression of CKD: follow-up of a randomized controlled trial B Cianciaruso, A Pota, V Bellizzi, D Di Giuseppe, L Di Micco, R Minutolo, ... American Journal of Kidney Diseases 54 (6), 1052-1061, 2009 | 115 | 2009 |
| The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice M Andreucci, T Faga, A Pisani, M Perticone, A Michael European Journal of Internal Medicine 39, 1-8, 2017 | 113 | 2017 |
| Effects of enzyme-replacement therapy in patients with Anderson–Fabry disease: a prospective long-term cardiac magnetic resonance imaging study M Imbriaco, A Pisani, L Spinelli, A Cuocolo, G Messalli, E Capuano, ... Heart 95 (13), 1103-1107, 2009 | 107 | 2009 |
| Atorvastatin improves the course of ischemic acute renal failure in aging rats M Sabbatini, A Pisani, F Uccello, V Serio, R Serù, R Paternò, ... Journal of the American Society of Nephrology 15 (4), 901-909, 2004 | 100 | 2004 |
| Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance E Ierardi, M Principi, R Francavilla, A Pisani, M Rendina, M Ingrosso, ... Alimentary pharmacology & therapeutics 15 (3), 371-377, 2001 | 99 | 2001 |
| Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement A Pisani, L Spinelli, M Sabbatini, MV Andreucci, D Procaccini, ... American journal of kidney diseases 46 (1), 120-127, 2005 | 83 | 2005 |
| Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study G Stallone, B Infante, G Grandaliano, C Bristogiannis, L Macarini, ... Nephrology Dialysis Transplantation 27 (9), 3560-3567, 2012 | 77 | 2012 |
Michele AndreucciUniversità Magna GraeciaEmail verificata su unicz.it
